Zobrazeno 1 - 10 of 17 pro vyhledávání: '"K L, Mettinger"'
1
Stroke before 55 years of age at Karolinska Hospital 1973-77. A study of 399 well-defined cases
Autor: C. E. Söderström, K. L. Mettinger, J. Neiman
Publikováno v: Acta Neurologica Scandinavica. 70:415-422
The etiological characteristics of cerebrovascular disease (CVD) before the age of 55 are reviewed in 399 patients admitted to the Department of Neurology, Karolinska Hospital, Stockholm, from 1973-77. The material was well-defined with regard to sub
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f23ea38c331bf7972955b0a6f326e91
https://doi.org/10.1111/j.1600-0404.1984.tb00846.x
Zobrazit plný text záznamu
2
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models
Autor: B, Sredni, R H, Xu, M, Albeck, U, Gafter, R, Gal, A, Shani, T, Tichler, J, Shapira, I, Bruderman, R, Catane, B, Kaufman, J K, Whisnant, K L, Mettinger, Y, Kalechman
Publikováno v: International journal of cancer. 65(1)
The immunomodulator AS101 has been demonstrated to exhibit radioprotective and chemoprotective effects in mice. Following phase-I studies, preliminary results from phase-II clinical trials on non-small-cell-lung-cancer patients showed a reduction in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e899fe5ea9de930efd2d97896b090be1
https://pubmed.ncbi.nlm.nih.gov/8543404
Zobrazit plný text záznamu
6
A randomized phase III study of rubitecan (ORA) vs. best choice (BC) in 409 patients with refractory pancreatic cancer report from a North-American multi-center study
Autor: A. D. Jacobs, S. Rivkin, Paul S. Ritch, P. D. Eisenberg, K. L. Mettinger, H. A. Burris
Publikováno v: Journal of Clinical Oncology. 22:4013-4013
4013 Background: Rubitecan (Orathecin), an oral topoisomerase I inhibitor, showed promising activity in pancreatic cancer in previous single-center Phase 2 studies in US and Europe. Our objective was to compare ORA with BC (physicians' best choice of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a51da38c3e4390f67c8d9e48a772efeb
https://doi.org/10.1200/jco.2004.22.90140.4013
Zobrazit plný text záznamu
7
Fibromuscular dysplasia and the brain. II. Current concept of the disease
Autor: K L Mettinger
Publikováno v: Stroke. 13:53-58
Eleven hundred cases from the literature of fibromuscular dysplasia (FMD) are reviewed including 300 cases with aortocranial lesions. The male-female ratio is 1:2, and the prevalence seems increased among Caucasians. The clinical diagnosis of FMD is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9037df86fa3429f078069ce34b4ba46
https://doi.org/10.1161/01.str.13.1.53
Zobrazit plný text záznamu
8
Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics
Autor: K Ericson, K L Mettinger
Publikováno v: Stroke. 13:46-52
The angiographic, clinical, and genetic characteristics of fibromuscular dysplasia (FMD) are reviewed in 37 patients (mean age 48 years) selected from a pool of 4000 angiograms of carotid or vertebral arteries. FMD was a neglected pathogenic factor i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa907fbee88a8f97ea74fad30af056f
https://doi.org/10.1161/01.str.13.1.46
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje